Bevacizumab in recurrent high-grade pediatric gliomas-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bevacizumab in recurrent high-grade pediatric gliomas

Published:2010-04-02 Issue:9 Volume:12 Page:985-990
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:Neuro-Oncology

Author:

Narayana A.,Kunnakkat S.,Chacko-Mathew J.,Gardner S.,Karajannis M.,Raza S.,Wisoff J.,Weiner H.,Harter D.,Allen J.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/12/9/985/4011926/noq033.pdf

Reference22 articles.

1. Pediatric brain tumors: Current treatment strategies and future therapeutic approaches

2. Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer

3. Bevacizumab for Advanced Breast Cancer

4. Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

5. Targeted therapies in the management of renal cell carcinoma: role of bevacizumab

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updates on management of gliomas in the molecular age;World Journal of Clinical Oncology;2024-02-24

2. Novel insights on genetics and epigenetics as clinical targets for paediatric astrocytoma;Clinical and Translational Medicine;2024-02

3. Chemotherapy in pediatric brain tumor and the challenge of the blood–brain barrier;Cancer Medicine;2023-11-23

4. Bench-to-bedside investigations of H3 K27-altered diffuse midline glioma: drug targets and potential pharmacotherapies;Expert Opinion on Therapeutic Targets;2023-11-02

5. Global Impact of Monoclonal Antibodies (mAbs) in Children: A Focus on Anti-GD2;Cancers;2023-07-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3